Combined anti-ages and antioxidant activities of different solvent extracts of Solanum elaeagnifolium Cav (Solanacea) fruits during ripening and related to their phytochemical compositions

Oxidative stress and advanced glycation end products (AGEs) are known as key factors for the development of diabetic complications such as retinopathy, cataract as well as atherosclerosis and neurodegenerative diseases, including Alzheimer’s diseases. In this context, natural products have been previously identified as promising sources for antioxidant and anti-glycation compounds. The current study focuses on the evaluation of antioxidant and glycation inhibitory activities of different solvent extracts of Solanum elaeagnifolium Cav (Solanaceae) fruits at different ripening stages. The results showed that antioxidant and anti-AGEs activities were significantly influenced by solvents polarities and ripening stages of S. elaeagnifolium Cav. With one exception, methanolic extract of overripe S. elaeagnifolium Cav fruit showed important protective effects against cellular oxidative stress. The aqueous extract showed the highest ABTS+ scavenging ability. Principal component analysis showed that total phenolic and flavonoid contents correlated well with observed antioxidants and anti-glycation activities. These results bring attention to the possible use of S. elaeagnifolium Cav as a valuable source of bioactive compounds exhibiting antioxidant effects and potentially alleviating diabetic complications

(+)-Neocadambine A and (-)-nauclederine isolated from the bark of Neolamarckia cadamba (Rubiaceae) as natural advanced glycation end products (AGEs) inhibitors

The phytochemical study on the dichloromethane extract of Neolamarckia cadamba (Roxb.) Bosser has afforded two indole alkaloids, (+)-neocadambine A (1) and (-)-nauclederine (2). Their structures were confirmed by extensive spectroscopic analysis and by comparing with the reported data. (+)-Neocadambine A (1) and (-)-nauclederine (2) exhibited potent inhibition activity of advanced glycation end products (AGEs) with IC50 values of 1.2 and 0.95 mM, respectively, while the latter was almost two times more potent than the standard, aminoguanidine (1.8 mM). This is the first report on the compounds isolated from this plant with AGEs inhibition activity. In addition, (-)-nauclederine (2) was isolated for the first time in the genus of Neolamarckia. Complete 1H-NMR and 13C-NMR of compound 2 were also reported

Du criblage anti-AGEs d’extraits végétaux à des pharmacophores et cibles thérapeutiques potentiels pour prévenir les rejets de greffe d’organes

International audienc

Proposer des solutions efficaces et sûres en phytothérapie

International audienceOffering effective and safe phytotherapy solutions. Using plants for health and wellbeing is a trend which pharmacies cannot escape. Regulations concerning plant-based products have evolved significantly over the last ten years. Pharmacists must ensure the products they stock are effective and safe.Le soin et la recherche du bien-être par les plantes sont une tendance à laquelle les pharmacies n’échappent pas. La réglementation concernant les produits à base de plantes a beaucoup évolué ces dix dernières années. Le pharmacien doit veiller à référencer des produits efficaces et sûrs.</p

Phytothérapie et troubles urogénitaux, sélectionner des produits efficaces et sûrs

International audienc

Du criblage anti-AGEs d’extraits végétaux à des pharmacophores et cibles thérapeutiques potentiels pour prévenir les rejets de greffe d’organes

International audienc

Comment venir à bout des mycoses

International audienc

Comment soulager les petits “bobos” des enfants par les thérapeutiques alternatives (2e partie)

International audienc

Prise en charge des petits bobos de bébé

International audienceLes parents d’un nourrisson sont souvent très préoccupés par les petits troubles pouvant affecter leur enfant, notamment lors des tous premiers mois. Ces “bobos” sont, de ce fait, très souvent évoqués au comptoir.</p

Place des thérapeutiques alternatives dans la prise en charge des allergies

International audienc